newsfilter
← Latest News
Business Wire·

AgeX Therapeutics Receives $4.5 Million From Exercise of Warrants

ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (“AgeX”, NYSE American: AGE), a biotechnology company focused on innovative therapeutics for human aging, announced today that it has received $4.5 million from the exercise of AgeX common stock warrants. Warrant holders purchased a total of 1,800,000 shares of AgeX common stock through the exercise of warrants at an exercise price of $2.50 per share. The warrants were issued to investors by AgeX during 2018. Any warrants that were not exercised have expired.